Waddill William D.

CIK 00015533386 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001553338

Recent Transactions

50 trades

Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-06-23−9,000→ 0 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-06-23$117.94/sh−9,000→ 7,825 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-06-23$16.54/sh+9,000→ 16,825 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2026-06-11+65,000→ 65,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-06-10$107.68/sh−9,000→ 7,825 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-06-10$16.54/sh+6,000→ 16,825 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-06-10−6,000→ 9,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-06-10−3,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-06-10$11.80/sh+3,000→ 10,825 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-29$11.80/sh+9,000→ 16,825 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-05-29$99.64/sh−9,000→ 7,825 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-05-29−9,000→ 3,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-02-06$8.31/sh+20,000→ 27,825 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-02-06$83.68/sh−20,000→ 7,825 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-02-06−20,000→ 0 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2026-01-02+2,695→ 7,825 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2026-01-02+3,762→ 3,762 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2025-12-16+7,819→ 64,930 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-10-10$69.25/sh−4,000→ 13,130 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-10-10$87.81/sh−8,000→ 5,130 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-10-10−12,000→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-10-10$6.98/sh+12,000→ 17,130 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-09-22$64.25/sh−4,000→ 5,130 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-08-27$59.25/sh−4,000→ 9,130 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2025-06-05+55,000→ 55,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-03-17$54.25/sh−4,000→ 13,130 total
Award
Protagonist Therapeutics, Inc$PTGX
Common Stock
2025-01-02+5,130→ 17,130 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2025-01-02+6,584→ 6,584 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-18$22.99/sh+16,733→ 57,111 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-17$22.04/sh−3,747→ 40,378 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-12-16$21.90/sh−3,748→ 44,125 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-09-10−8,000→ 0 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-09-10$45.00/sh−8,000→ 12,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-09-10$12.88/sh+8,000→ 20,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-07-24$12.88/sh+8,000→ 20,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-07-24$40.00/sh−8,000→ 12,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-07-24−8,000→ 8,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-06-07−8,000→ 16,000 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-06-07$12.88/sh+8,000→ 20,000 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-06-07$35.00/sh−8,000→ 12,000 total
Award
Annexon, Inc.$ANNX
Stock Option (Right to Buy)
2024-06-05+44,000→ 44,000 total
Award
Turnstone Biologics Corp.
Stock Option (Right to Buy)
2024-06-03+12,770→ 12,770 total
Award
Turnstone Biologics Corp.
Stock Option (Right to Buy)
2024-04-15+25,540→ 25,540 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-03-01−12,975→ 0 total
Exercise/Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-03-01$6.09/sh+12,975→ 24,975 total
Sale
Protagonist Therapeutics, Inc$PTGX
Common Stock
2024-03-01$31.34/sh−12,975→ 12,000 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-11$37.81/sh−2,634→ 49,170 total
Sale
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2024-01-11$38.59/sh−1,300→ 47,870 total
Award
Protagonist Therapeutics, Inc$PTGX
Stock Option (right to buy)
2024-01-02+25,700→ 25,700 total
Award
ARROWHEAD PHARMACEUTICALS, INC.$ARWR
Common Stock
2023-12-15$25.41/sh+14,987→ 51,804 total

Companies

Recent Filings

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160

View on SEC.gov